Aprila Tablet 30 mg contains Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor designed for the treatment of inflammatory conditions such as psoriatic arthritis and moderate to severe plaque psoriasis. By regulating key inflammatory pathways, Aprila helps reduce joint pain, swelling, stiffness, and skin lesions, providing patients with significant relief and improved daily functioning.
The 30 mg dosage represents the standard maintenance dose, providing consistent therapeutic effects for long-term management of chronic inflammatory disorders. Aprila Tablet offers an effective oral alternative to injectable biologic therapies, making it convenient for home administration.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Apremilast, the active ingredient in Aprila Tablet, works by selectively inhibiting phosphodiesterase 4 (PDE4), an enzyme involved in inflammatory signaling:
Reduces Pro-inflammatory Cytokines: Lowers TNF-alpha, IL-17, and IL-23 levels, which contribute to joint inflammation and skin lesions.
Enhances Anti-inflammatory Mediators: Increases production of IL-10, helping restore balance in immune response.
Controls Symptoms: Alleviates pain, swelling, and stiffness in psoriatic arthritis, and reduces redness, scaling, and itching in psoriasis.
Oral Therapy: Offers a convenient daily tablet for patients who prefer oral medication over injections.
By targeting inflammation at a molecular level, Aprila provides meaningful relief and supports improved mobility, skin appearance, and quality of life.
Aprila Tablet 30 mg is indicated for:
Active psoriatic arthritis in adults to reduce joint pain, swelling, and stiffness
Moderate to severe plaque psoriasis in adults to reduce skin lesions, scaling, and itching
Long-term maintenance therapy for patients who have tolerated dose escalation from 10 mg or 20 mg
Patients seeking an oral therapy alternative to injectable biologics
This medication is prescribed under medical supervision as part of a comprehensive treatment plan that may include lifestyle changes and supportive care.
Initial Titration: Patients usually start on lower doses (10 mg or 20 mg) to reduce gastrointestinal side effects, gradually increasing to the 30 mg twice-daily maintenance dose.
Maintenance Dose: 30 mg orally twice daily, with or without food.
Swallow the tablet whole with water; do not crush or chew.
Take at consistent times each day to maintain steady therapeutic levels.
Regular follow-up is necessary to monitor efficacy, tolerability, and overall health.
Effectively reduces joint pain, swelling, and stiffness in psoriatic arthritis
Improves appearance and symptoms of plaque psoriasis
Supports mobility, daily functioning, and quality of life
Oral formulation allows convenient at-home administration
Maintains consistent anti-inflammatory effects with the 30 mg maintenance dose
Aprila Tablet is generally well tolerated, though some patients may experience:
Diarrhea, nausea, or abdominal discomfort
Headache
Fatigue
Weight loss
Rarely, mood changes, depression, or suicidal thoughts
Patients experiencing severe or persistent symptoms should consult their healthcare provider promptly.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Use with caution in patients with depression, significant weight loss, or pre-existing gastrointestinal conditions.
Not recommended during pregnancy or breastfeeding unless specifically prescribed by a physician.
Inform your doctor about all medications to avoid potential drug interactions.
Regular monitoring of clinical response, weight, and overall health is advised.
Store below 30°C in a cool, dry place, away from light and moisture. Keep out of reach of children.
Aprila Tablet 30 mg (Apremilast) is a safe and effective oral therapy for managing psoriatic arthritis and plaque psoriasis, providing sustained symptom control, improved physical function, and enhanced quality of life under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet